T. Rowe Price Associates, Inc. 13D and 13G filings for Longboard Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | T. Rowe Price Associates, Inc. | 2,909,257 7.500% | 1,282,275 (+78.81%) | Filing |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | T. Rowe Price Associates, Inc. | 1,626,982 7.600% | 116,021 (+7.68%) | Filing |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | T. Rowe Price Associates, Inc. | 1,510,961 11.100% | -513,655 (-25.37%) | Filing |
| 2022-02-14 2:35 pm Sale | 2021-12-31 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | T. Rowe Price Associates, Inc. | 2,024,616 14.900% | -278,133 (-12.08%) | Filing |